Will FDA Inspect a New Coating Supplier for a Class III Combination Medical Device?

B

Ballroom Blitz

Hi I am explaining to my RD/Quality team that there is a high probability that our polymer coating supplier we are sourcing our polymer for a class III combination product (drug eluting device) will likely be audited by FDA as part of the Pre-approval inspection.
Several reasons:
1. We have never submitted a PMA as a manufacturer
2. it is a new novel polymer developed by a supplier that the FDA has not visited before
3. the coating is most likely considered non-compendial expcipient since it the portion (coating) that assist in the drug elution
4.this supplier does not have a MAF and they are providing us the documentation for the manufacturing section of the PMA; however, based on above, I do believe that this supplier is critical and will mostly be audited.

I could really use some assistance in examples or where in the regulation it states this supplier would be subject to being audited.

The MAF guidance suggest the supplier would be audited since they are creating two different polymer coating for us- base and topcoat and of they had a MAF, they would be subject to an audit.

"Good Manufacturing Practice Regulations for Medical Devices

Organizations or persons who submit IDEs, 510(k)s, or PMAs, or other device-related submissions to FDA may use contract manufacturers, sterilizers, packagers, etc., in the manufacture of their devices. The latter, for trade secret or confidentiality purposes, may submit a description of its facilities, manufacturing procedures and processes, and quality control procedures in an MAF rather than provide this information directly to the client for inclusion in its submission.

In their evaluation of the client's submission, FDA may inspect the MAF holder's facilities and manufacturing operations. When the MAF holder's operation is subject to the Good Manufacturing Practice (GMP) regulations for medical devices (21 CFR 820), the MAF must address all appropriate GMP requirements applicable to the MAF holder's operation. A client's submission may be adversely affected if the MAF is incomplete or inaccurate. This is especially true in the case of a PMA because of the statutory requirement that a PMA contain a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and when relevant, packing and installation of the device. "

Plus the drug eluting stent guidance also suggest the polymer (excipient)supplier would be audited.

Does anyone have any links that would assist me in providing a stronger response to my team.?
Of course the Supplier controls and purchasing controls must be followed; however, since this is a new business, and a new polymer developed for us and they do not have a MAF for either base coat(existing) or top coat; m thinking is they will be audited by the FDA assuming the documentation submitted in the PMA is in sufficient.
your assistance is appreciated.
Thank you for your time.
 
Ajit Basrur

Ajit Basrur

Leader
Admin
Re: Will FDA Inspect a New Coating Supplier for a Class III Combination Medical Devic

Hello Ballroom Blitz

Did you refer the INSPECTION OF MEDICAL DEVICE MANUFACTURERS?

Refer section 2a (scheduling of inspections) will be prioritized for Pre-Market and Pre-Clearance inspections under MDUFMA (Inspections of manufacturers of devices with a pending PMA approval and also for Manufacturers of Class III devices that have never been inspected.
.
 

Attachments

  • ucm244277.pdf
    706.8 KB · Views: 140
P

praveensh

Registered
Hi Ballroom Blitz,
I'm looking to improve efficiency on our stent coaters and was wondering if you could share some lessons learnt. We use ultrasonic nozzles with MediCoat sprayers from Sonotek.

Thanks,
Praveen





Ballroom Blitz said:
Hi I am explaining to my RD/Quality team that there is a high probability that our polymer coating supplier we are sourcing our polymer for a class III combination product (drug eluting device) will likely be audited by FDA as part of the Pre-approval inspection.
Several reasons:
1. We have never submitted a PMA as a manufacturer
2. it is a new novel polymer developed by a supplier that the FDA has not visited before
3. the coating is most likely considered non-compendial expcipient since it the portion (coating) that assist in the drug elution
4.this supplier does not have a MAF and they are providing us the documentation for the manufacturing section of the PMA; however, based on above, I do believe that this supplier is critical and will mostly be audited.

I could really use some assistance in examples or where in the regulation it states this supplier would be subject to being audited.

The MAF guidance suggest the supplier would be audited since they are creating two different polymer coating for us- base and topcoat and of they had a MAF, they would be subject to an audit.

"Good Manufacturing Practice Regulations for Medical Devices

Organizations or persons who submit IDEs, 510(k)s, or PMAs, or other device-related submissions to FDA may use contract manufacturers, sterilizers, packagers, etc., in the manufacture of their devices. The latter, for trade secret or confidentiality purposes, may submit a description of its facilities, manufacturing procedures and processes, and quality control procedures in an MAF rather than provide this information directly to the client for inclusion in its submission.

In their evaluation of the client's submission, FDA may inspect the MAF holder's facilities and manufacturing operations. When the MAF holder's operation is subject to the Good Manufacturing Practice (GMP) regulations for medical devices (21 CFR 820), the MAF must address all appropriate GMP requirements applicable to the MAF holder's operation. A client's submission may be adversely affected if the MAF is incomplete or inaccurate. This is especially true in the case of a PMA because of the statutory requirement that a PMA contain a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and when relevant, packing and installation of the device. "

Plus the drug eluting stent guidance also suggest the polymer (excipient)supplier would be audited.

Does anyone have any links that would assist me in providing a stronger response to my team.?
Of course the Supplier controls and purchasing controls must be followed; however, since this is a new business, and a new polymer developed for us and they do not have a MAF for either base coat(existing) or top coat; m thinking is they will be audited by the FDA assuming the documentation submitted in the PMA is in sufficient.
your assistance is appreciated.
Thank you for your time.
Click to expand...
 
You must log in or register to reply here.
Thread starter Similar threads Forum Replies Date
A What to expect if FDA wants to inspect a Class 1 Medical Device Manufacturer ISO 13485:2016 - Medical Device Quality Management Systems 1
S How often does the FDA inspect organisations outside of the USA? US Food and Drug Administration (FDA) 12
Ed Panek Looking for help... FDA Pre Sub, IVD, Investigational level experience US Medical Device Regulations 0
U How should we build the FDA inspection preparedness team for FDA inspections at factories? General Auditing Discussions 0
D FDA combo product-need to define direct & indirect impact regarding safety,quality & regulatory.Can anyone point me in right direction-SupplierMgmt 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
B What is meant by "post production" if the device is yet to receive FDA approval? ISO 14971 - Medical Device Risk Management 4
B FDA Requirements for medical device to be used for training purposes only US Food and Drug Administration (FDA) 9
M Class III IVD PMA Amendment to FDA Medical Device and FDA Regulations and Standards News 1
L Verification of wireless QoS and coexistence during FDA certification of medical devices Medical Device and FDA Regulations and Standards News 1
W Notify FDA of Change of Ownership? US Food and Drug Administration (FDA) 2
G FDA requirements for risk analysis US Food and Drug Administration (FDA) 2
V Anyone have templates for FDA GMP Guidelines for supplement manufacturers? US Food and Drug Administration (FDA) 0
N FDA mechanical bench testing Manufacturing and Related Processes 5
V Regulatory consultants for US FDA ANDA - pharma / drug products Consultants and Consulting 0
M Clinical evaluation process of FDA and MDR Medical Device and FDA Regulations and Standards News 2
S Is it possible to obtain FDA clearance (510k) without meeting QSR? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
P Biocompatibility testing ISO-10993 for FDA submission Other Medical Device Related Standards 7
Ed Panek FDA Submission Question US Medical Device Regulations 3
Y The day after the FDA US Food and Drug Administration (FDA) 2
U FDA foreign inspection and COVID19 US Medical Device Regulations 4
Y Convenience pack FDA US Food and Drug Administration (FDA) 3
B FDA regulations medical device prescription fulfillment DME question US Medical Device Regulations 0
N FDA medical devices US Food and Drug Administration (FDA) 1
R US FDA 510k Australia TGA US Food and Drug Administration (FDA) 0
B How FDA define a new variant/generation or a new device US Medical Device Regulations 11
G FDA Annual Registration and Listing US Food and Drug Administration (FDA) 7
T Book Excerpt: Drugs and the FDA: Safety, Efficacy, and the Public’s Trust Book, Video, Blog and Web Site Reviews and Recommendations 0
E The FDA regulations (21 CFR 312.3): Is it allowable that IND sponsor involves more than one individual or organization? Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 0
P Looking for Korean FDA Drug Master File requirements for packaging systems. Other Medical Device and Orthopedic Related Topics 1
M IEC 62366 Hazard-related Use Scenario vs FDA Critical Task EU Medical Device Regulations 3
N Free sale and FDA US Food and Drug Administration (FDA) 1
N FDA class 1 US Food and Drug Administration (FDA) 6
G UDI in EU vs FDA EU Medical Device Regulations 1
S Initial Audit FDA US Medical Device Regulations 3
T FDA PMA review process - advisory panel timing? Other Medical Device and Orthopedic Related Topics 0
E FDA & Internal Audits US Medical Device Regulations 3
N Importing into US without 510K/FDA Clearance US Medical Device Regulations 1
N FDA class 2 Device QS Requirements US Food and Drug Administration (FDA) 2
T FDA labeling requirements US Food and Drug Administration (FDA) 2
S FDA Contract Manufacturer and Applicant US Food and Drug Administration (FDA) 0
R IVD Software FDA/CLIA doubts Medical Device and FDA Regulations and Standards News 1
R IVD software FDA and CLIA US Food and Drug Administration (FDA) 2
T FDA level of concern vs IEC 62304 safety classification - 510(k) exempt device Other US Medical Device Regulations 13
K Change in address on ERLM US FDA: Implications to import US Medical Device Regulations 0
V FDA 510K - Pre Submission Query US Food and Drug Administration (FDA) 6
M Document Control ISO and FDA ISO 13485:2016 - Medical Device Quality Management Systems 7
C FDA 510k documentation requirements US Food and Drug Administration (FDA) 1
T Link GMDN code and FDA product code US Medical Device Regulations 5
cgaro62 Does FDA apply to a non-medical 13485 certified custom manufacturing company? ISO 13485:2016 - Medical Device Quality Management Systems 11
M How does FDA determine OAI and VAI after inspection? ISO 13485:2016 - Medical Device Quality Management Systems 0

Similar threads

Top Bottom